Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL259480 | 0.91 | — | — | |
| Bromide SCHEMBL6298962 | 0.89 | ALDH1A1 (0.62) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| Bromide SCHEMBL6298964 | 0.89 | ALDH1A1 (0.62) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| Hydrochloric Acid SCHEMBL14685862 | 0.89 | ALDH1A1 (0.62) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| Bromide SCHEMBL3960541 | 0.89 | ALDH1A1 (0.62) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| Acetic Acid SCHEMBL3851421 | 0.86 | ALDH1A1 (0.55) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| Nitric Acid SCHEMBL31591110 | 0.83 | ALDH1A1 (0.51) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| SCHEMBL13176554 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| SCHEMBL459428 | 0.78 | ALDH1A1 (0.50) | ALDH1A1KMT2AKDM4EMEN1LMNA | |
| SCHEMBL2642153 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | claimed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| CN-119731312-A | Microbial cell factory for producing thiamine | 拜奥信尼亚私营有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | claimed |
| EP-4370653-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | Biosyntia ApS (DK) | 2024-05-22 | — | — | EP | claimed |
| CN-117797244-A | Homologous cell regeneration medicine for repairing DNA and preparation method thereof | 北京北美抗衰老医学研究院 | 2024-04-02 | — | — | CN | claimed |
| WO-2024013212-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2024-01-18 | — | — | WO | claimed |
| CN-116694286-A | Liquid light curing glue for electronic product screen and preparation method and application thereof | 深圳市汇和兴科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| WO-2023285585-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2023-01-19 | — | — | WO | claimed |
| CN-1317051-A | HMP-P rinase and TMP-PPase from arabidopsis thaliana and their use in herbicide screening | SINGENPE AG (CH) | 2001-10-10 | — | — | CN | claimed |
| EP-1093520-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | Syngenta Participations AG (CH) | 2001-04-25 | — | — | EP | claimed |
| WO-2000000623-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | SYNGENTA PARTICIPATIONS AG (CH) | 2000-01-06 | — | — | WO | claimed |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | disclosed |
| WO-2025210159-A3 | CELL FACTORY FOR PRODUCTION OF SULFUROL | BIOSYNTIA APS (DK) | 2025-11-20 | — | — | WO | disclosed |
| WO-2025210159-A2 | CELL FACTORY FOR PRODUCTION OF SULFUROL | BIOSYNTIA APS (DK) | 2025-10-09 | — | — | WO | disclosed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | disclosed |
| CN-1317051-A | HMP-P rinase and TMP-PPase from arabidopsis thaliana and their use in herbicide screening | SINGENPE AG (CH) | 2001-10-10 | — | — | CN | disclosed |
| EP-1093520-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | Syngenta Participations AG (CH) | 2001-04-25 | — | — | EP | disclosed |
| EP-1059354-A2 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | Ceres Incorporated (US) | 2000-12-13 | — | — | EP | disclosed |
| WO-2000000623-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | SYNGENTA PARTICIPATIONS AG (CH) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | AHCY, SHMT1, MTHFD1 | ALDH1A1 624/4885KMT2A 2677/4885KDM4E 2990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.